Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7136
+0.0046 (0.65%)
Apr 17, 2025, 4:00 PM EDT - Market closed

RVPH Stock Forecast

RVPH's stock price has decreased by -78.57% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for RVPH stock have an average target of 10, with a low estimate of 7.00 and a high estimate of 17. The average target predicts an increase of 1,301.35% from the current stock price of 0.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $10 $8.00 $17
Change +880.94% +1301.3% +1021.1% +2282.3%

Analyst Ratings

The average analyst rating for RVPH stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 224444
Buy 111111
Hold 110000
Sell 000000
Strong Sell 000000
Total 445555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$15$8
Strong Buy Maintains $15$8 +1,021.08% Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$14$11
Strong Buy Maintains $14$11 +1,441.48% Jan 22, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$15
Strong Buy Maintains $15 +2,002.02% Jan 21, 2025
Maxim Group
Maxim Group
Strong Buy
Upgrades
$7
Strong Buy Upgrades $7 +880.94% Jan 10, 2025
Roth MKM
Roth MKM
Strong Buy
Initiates
$7
Strong Buy Initiates $7 +880.94% Jan 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 282.38M
Revenue Next Year
n/a
EPS This Year
-0.82
from -0.90
EPS Next Year
-0.46
from -0.82
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
---144.62M282.38M
Revenue Growth
----95.26%---
EPS
-1.24-0.58-1.45-1.65-0.90-0.82-0.46-0.43
EPS Growth
--------
Forward PE
--------
No. Analysts -----953
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -0.47 -0.27 -0.44
Avg -0.82 -0.46 -0.43
Low -0.98 -0.69 -0.41

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.